| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
13,404 |
4,948 |
$813K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48,530 |
29,643 |
$229K |
| 80053 |
Comprehensive metabolic panel |
37,246 |
26,428 |
$209K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
32,853 |
16,788 |
$169K |
| 36415 |
Collection of venous blood by venipuncture |
65,029 |
29,981 |
$156K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
9,156 |
7,801 |
$127K |
| 80061 |
Lipid panel |
13,916 |
12,186 |
$78K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,147 |
6,588 |
$77K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14,958 |
12,565 |
$71K |
| 85027 |
|
11,874 |
8,448 |
$38K |
| 80164 |
|
2,839 |
2,246 |
$23K |
| 83735 |
|
4,171 |
2,903 |
$19K |
| 82140 |
|
2,167 |
1,225 |
$18K |
| 80202 |
|
1,732 |
477 |
$16K |
| 80177 |
|
1,967 |
1,574 |
$15K |
| 85610 |
|
6,819 |
1,717 |
$15K |
| 82607 |
|
1,665 |
1,376 |
$14K |
| 86140 |
|
3,443 |
1,733 |
$12K |
| 83880 |
|
505 |
365 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
8,712 |
3,394 |
$11K |
| 84439 |
|
1,821 |
1,524 |
$8K |
| 81001 |
|
6,603 |
4,916 |
$8K |
| 82728 |
|
919 |
732 |
$7K |
| 83970 |
|
283 |
219 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
141 |
131 |
$7K |
| 85652 |
|
3,241 |
1,671 |
$7K |
| 82746 |
|
700 |
588 |
$6K |
| 80076 |
|
1,487 |
1,248 |
$6K |
| 84132 |
|
2,376 |
1,455 |
$6K |
| 84100 |
|
1,494 |
1,052 |
$5K |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
33,626 |
16,540 |
$5K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
45,010 |
23,700 |
$4K |
| 83540 |
|
1,060 |
828 |
$4K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
278 |
206 |
$4K |
| 87631 |
|
47 |
44 |
$4K |
| 85730 |
|
867 |
524 |
$3K |
| 84153 |
|
456 |
379 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
42 |
27 |
$3K |
| 84480 |
|
304 |
235 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
71 |
66 |
$2K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
7,560 |
4,204 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
125 |
115 |
$1K |
| 87581 |
|
165 |
154 |
$1K |
| 87481 |
|
136 |
114 |
$1K |
| 85018 |
|
788 |
380 |
$1K |
| 85014 |
|
788 |
380 |
$1K |
| 84436 |
|
322 |
237 |
$1K |
| 84550 |
|
391 |
319 |
$946.12 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
16 |
$821.28 |
| 84134 |
|
65 |
53 |
$806.13 |
| 87500 |
|
144 |
126 |
$774.48 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
27 |
12 |
$757.79 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
75 |
73 |
$667.29 |
| 87493 |
|
104 |
49 |
$657.35 |
| 87556 |
|
119 |
110 |
$633.46 |
| 80185 |
|
122 |
51 |
$596.03 |
| 85045 |
|
388 |
341 |
$578.74 |
| 87486 |
|
118 |
109 |
$533.33 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
124 |
114 |
$533.33 |
| 87541 |
|
119 |
110 |
$533.33 |
| 87496 |
|
118 |
109 |
$533.33 |
| 87640 |
|
125 |
115 |
$533.33 |
| 87498 |
|
125 |
115 |
$533.33 |
| 87561 |
|
119 |
110 |
$533.33 |
| 87641 |
|
124 |
114 |
$533.33 |
| 87653 |
|
125 |
115 |
$533.33 |
| 83550 |
|
164 |
111 |
$479.40 |
| 87503 |
|
131 |
115 |
$444.22 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18 |
17 |
$411.68 |
| 82248 |
|
230 |
177 |
$394.74 |
| 82550 |
|
43 |
25 |
$235.50 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
46 |
42 |
$188.82 |
| 87088 |
|
17 |
14 |
$72.13 |
| 82040 |
|
12 |
12 |
$46.80 |
| 0112U |
|
123 |
114 |
$0.00 |